False Claims Act

Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Fierce Pharma
Sanofi
GSK
FDA
Zantac
DOJ
cancer
product recalls
False Claims Act
Flag link:
Whistleblowing in the Time of COVID-19
Whistleblowing in the Time of COVID-19
CP WIre
whistleblowers
whistleblower lawsuits
COVID-19
fraud
False Claims Act
Flag link:
Feds target Mallinckrodt after joining Medicaid rebate suit worth 'hundreds of millions'
Feds target Mallinckrodt after joining Medicaid rebate suit worth 'hundreds of millions'
Fierce Pharma
Mallinckrodt
H.P. Acthar Gel
Medicaid fraud
Medicaid
whistleblower lawsuit
False Claims Act
Flag link:
Biogen hit back at whistleblowing sales manager, jury finds, levying $6M in damages
Biogen hit back at whistleblowing sales manager, jury finds, levying $6M in damages
Fierce Pharma
Biogen
whistleblower lawsuit
retaliation claims
False Claims Act
Flag link:
Blowing the Whistle on Private Insurance Fraud
Blowing the Whistle on Private Insurance Fraud
CP Wire
False Claims Act
insurance fraud
California
Illinois
whistleblowers
whistleblower lawsuits
Flag link:
DOJ Encourages Whistleblowers in War on Opioid Abuse
DOJ Encourages Whistleblowers in War on Opioid Abuse
CP Wire
DOJ
opioids
opioid crisis
whistleblowers
whistleblower lawsuits
False Claims Act
Insys
Flag link:
Medtronic can’t slip whistleblower’s CRM suit
Medtronic can’t slip whistleblower’s CRM suit
Mass Device
Medtronic
devices
False Claims Act
kickbacks
whistleblower lawsuits
Flag link:
A Busy Week for the Supreme Court in FCA Matters
A Busy Week for the Supreme Court in FCA Matters
FDA Law Blog
FDA
False Claims Act
Gilead Sciences
Flag link:
Court May Confirm the Rigorous Materiality Standard Required by the False Claims Act
Court May Confirm the Rigorous Materiality Standard Required by the False Claims Act
FDA Law Blog
FDA
False Claims Act
Supreme Court
Flag link:
United Therapeutics pays $210M to resolve kickback probe
United Therapeutics pays $210M to resolve kickback probe
BioPharma Dive
United Therapeutics
kickbacks
DOJ
False Claims Act
Flag link:
Appeals court tosses whistleblower suit against Biotronik
Appeals court tosses whistleblower suit against Biotronik
Mass Device
Biotronik
whistleblower lawsuits
devices
kickbacks
False Claims Act
Flag link:
J&J loses bid to stay FCA verdict
J&J loses bid to stay FCA verdict
Mass Device
JNJ
DePuy Ortho
hip implants
False Claims Act
devices
Pinnacle Hip
Flag link:
Fifth Circuit Upholds Summary Judgement for Solvay Pharmaceuticals in Off-Label and Anti-Kickback FCA Case
Fifth Circuit Upholds Summary Judgement for Solvay Pharmaceuticals in Off-Label and Anti-Kickback FCA Case
FDA Law Blog
Solvay
kickbacks
False Claims Act
off-label
Flag link:
AmerisourceBergen-owned specialty pharmacy to pay $13.4M to settle kickback allegations
AmerisourceBergen-owned specialty pharmacy to pay $13.4M to settle kickback allegations
Bizjournals.com
AmerisourceBergen
kickbacks
False Claims Act
Novartis
Exjade
Flag link:
C.R. Bard faces DoJ FCA probe, posts Q2 earnings
C.R. Bard faces DoJ FCA probe, posts Q2 earnings
Mass Device
CR Bard
DOJ
False Claims Act
earnings
devices
Flag link:
Celgene to fork over $280M to wrap a whistleblower's Revlimid marketing claims
Celgene to fork over $280M to wrap a whistleblower's Revlimid marketing claims
Fierce Pharma
Celgene
Revlimid
whistleblowers
off-label
False Claims Act
Flag link:
How Are Whistleblowers Paid
whistleblowers
False Claims Act
Flag link:
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
Bloomberg
Sanofi
False Claims Act
Amphastar
generics
patents
Flag link:
Charles River Laboratories International Inc. Agrees to Pay United States $1.8 Million to Settle False Claims Act Allegations
Charles River Laboratories International Inc. Agrees to Pay United States $1.8 Million to Settle False Claims Act Allegations
Department of Justice
Charles River Laboratories
False Claims Act
DOJ
NIH
Flag link:
First Circuit Rejects Fraud-on-FDA Allegations Under False Claims Act
First Circuit Rejects Fraud-on-FDA Allegations Under False Claims Act
FDA Law Blog
FDA
False Claims Act
whistleblower lawsuits
devices
off-label
Flag link:

Pages